FR2413405B1 - - Google Patents

Info

Publication number
FR2413405B1
FR2413405B1 FR7900016A FR7900016A FR2413405B1 FR 2413405 B1 FR2413405 B1 FR 2413405B1 FR 7900016 A FR7900016 A FR 7900016A FR 7900016 A FR7900016 A FR 7900016A FR 2413405 B1 FR2413405 B1 FR 2413405B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7900016A
Other versions
FR2413405A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of FR2413405A1 publication Critical patent/FR2413405A1/fr
Application granted granted Critical
Publication of FR2413405B1 publication Critical patent/FR2413405B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
FR7900016A 1978-01-03 1979-01-02 Nouveaux derives d'oleandomycine, leur procede de production et composition pharmaceutique les contenant Granted FR2413405A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/866,891 US4133950A (en) 1978-01-03 1978-01-03 4"-Deoxy-4"-carbamate and dithiocarbamate derivatives of oleandomycin and its esters

Publications (2)

Publication Number Publication Date
FR2413405A1 FR2413405A1 (fr) 1979-07-27
FR2413405B1 true FR2413405B1 (fr) 1981-04-17

Family

ID=25348657

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7900016A Granted FR2413405A1 (fr) 1978-01-03 1979-01-02 Nouveaux derives d'oleandomycine, leur procede de production et composition pharmaceutique les contenant

Country Status (11)

Country Link
US (1) US4133950A (fr)
JP (1) JPS5495586A (fr)
BE (1) BE873268A (fr)
DE (1) DE2900119C2 (fr)
DK (1) DK149629C (fr)
FR (1) FR2413405A1 (fr)
GB (1) GB2011891B (fr)
IE (1) IE47968B1 (fr)
IT (1) IT1109927B (fr)
LU (1) LU80745A1 (fr)
NL (1) NL175525C (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4316010A (en) * 1981-01-02 1982-02-16 Pfizer Inc. Cis-C3 "C4 "-carbonate derivatives of O-demethyloleandomycin and intermediates therefor
US4427663A (en) 1982-03-16 1984-01-24 Merck & Co., Inc. 4"-Keto-and 4"-amino-4"-deoxy avermectin compounds and substituted amino derivatives thereof
GB8521402D0 (en) * 1985-08-28 1985-10-02 Beecham Group Plc Chemical compounds

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3869445A (en) * 1973-05-03 1975-03-04 Abbott Lab 4{41 -O-sulfonyl erythromycin-9-O-oxime derivatives
US3884904A (en) * 1973-06-21 1975-05-20 Abbott Lab 11-Substituted erythromycin B derivatives
US3884903A (en) * 1973-06-21 1975-05-20 Abbott Lab 4{41 -Deoxy-4{41 -oxoerythromycin B derivatives
US4063014A (en) * 1975-06-12 1977-12-13 Abbott Laboratories 4"-O-sulfonyl erythromycin-9-O-oxime derivatives
US4069379A (en) * 1976-07-08 1978-01-17 Pfizer Inc. Semi-synthetic oleandomycins
US4085119A (en) * 1977-02-04 1978-04-18 Pfizer Inc. 4-Substituted amino derivatives of oleandomycin
US4090017A (en) * 1977-02-04 1978-05-16 Pfizer Inc. 4-Deoxy-4-substituted amino derivatives of oleandomycin
SE445223B (sv) * 1977-02-04 1986-06-09 Pfizer Sett att framstella 4"-amino-erytomylin-a-derivat
US4125705A (en) * 1977-02-04 1978-11-14 Pfizer Inc. Semi-synthetic 4-amino-oleandomycin derivatives
SE446340B (sv) * 1977-05-11 1986-09-01 Pfizer Sett att framstella halvsyntetiska 4"-sulfonylamino-oleandomycinderivat
US4098993A (en) * 1977-07-25 1978-07-04 Pfizer Inc. Semi-synthetic 4-ureido-oleandomycin derivatives
US4124755A (en) * 1978-01-03 1978-11-07 Pfizer Inc. 11-Alkanoyl-4"-deoxy-4"-isonitrilo-oleandomycin derivatives

Also Published As

Publication number Publication date
BE873268A (fr) 1979-07-02
DK1479A (da) 1979-07-04
LU80745A1 (fr) 1979-09-07
GB2011891B (en) 1982-05-26
FR2413405A1 (fr) 1979-07-27
DK149629B (da) 1986-08-18
IT1109927B (it) 1985-12-23
JPS5747198B2 (fr) 1982-10-07
DK149629C (da) 1987-02-02
US4133950A (en) 1979-01-09
DE2900119A1 (de) 1979-07-05
NL175525C (nl) 1984-11-16
IE790002L (en) 1979-07-03
DE2900119C2 (de) 1983-10-27
NL175525B (nl) 1984-06-18
GB2011891A (en) 1979-07-18
IT7919015A0 (it) 1979-01-02
IE47968B1 (en) 1984-08-08
JPS5495586A (en) 1979-07-28
NL7900004A (nl) 1979-07-05

Similar Documents

Publication Publication Date Title
AU3898778A (fr)
AU3803078A (fr)
AU73950S (fr)
AU3892778A (fr)
BG26014A1 (fr)
BG25875A1 (fr)
BE871570A (fr)
BG25806A1 (fr)
BG25814A2 (fr)
BG25816A1 (fr)
BG25818A1 (fr)
BG25835A1 (fr)
BG25836A1 (fr)
BG25842A1 (fr)
BG25843A1 (fr)
BG25849A1 (fr)
BG25854A1 (fr)
BG25857A1 (fr)
BG25858A1 (fr)
BG25871A1 (fr)
BG25872A1 (fr)
BG25874A1 (fr)
BG26015A1 (fr)
BG25879A1 (fr)
BG25889A1 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse